lenalidomide has been researched along with Herpes Zoster in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Jiao, B; Wu, G; Zhang, X | 1 |
| Engelhardt, M; Kleber, M; Knop, S; König, C; Reinhardt, H; Wäsch, R | 1 |
2 other study(ies) available for lenalidomide and Herpes Zoster
| Article | Year |
|---|---|
Refractory postherpetic neuralgia in a multiple myeloma patient with lenalidomide maintenance therapy: a case report.
Topics: Antiviral Agents; Herpes Zoster; Humans; Lenalidomide; Multiple Myeloma; Neuralgia, Postherpetic | 2022 |
Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
Topics: Acyclovir; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibiotic Prophylaxis; Antiviral Agents; Encephalitis, Varicella Zoster; Female; Germany; Herpes Simplex; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Incidence; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Polyradiculopathy; Risk Factors; Simplexvirus; Thalidomide | 2014 |